17089-420 NDC - MICOX (ASPERGILLUS NIGER VAR. NIGER - CANDIDA ALBICANS - CENTELLA ASIATICA - MALIC ACID - MERCURIC CHLORIDE - RHIZOPUS STOLONIFER - SODIUM DIETHYL OXALACETATE - SULFUR - TABEBUIA IMPETIGINOSA BARK -)

Drug Information

Product NDC: 17089-420

Proprietary Name: MICOX

Non Proprietary Name: ASPERGILLUS NIGER VAR. NIGER - CANDIDA ALBICANS - CENTELLA ASIATICA - MALIC ACID - MERCURIC CHLORIDE - RHIZOPUS STOLONIFER - SODIUM DIETHYL OXALACETATE - SULFUR - TABEBUIA IMPETIGINOSA BARK -

Active Ingredient(s):
  • 30 [hp_X]/30mL ASPERGILLUS NIGER VAR. NIGER;
  • 30 [hp_X]/30mL CANDIDA ALBICANS;
  • 6 [hp_X]/30mL CENTELLA ASIATICA;
  • 12 [hp_X]/30mL MALIC ACID;
  • 6 [hp_X]/30mL MERCURIC CHLORIDE;
  • 30 [hp_X]/30mL RHIZOPUS STOLONIFER;
  • 12 [hp_X]/30mL SODIUM DIETHYL OXALACETATE;
  • 6 [hp_X]/30mL SULFUR;
  • 4 [hp_X]/30mL TABEBUIA IMPETIGINOSA BARK


Administration Route(s): ORAL

Dosage Form(s): SOLUTION/ DROPS

Pharmacy Class(es):
  • Allergens [CS];
  • Allergens [CS];
  • Allergens [CS];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Fungal Proteins [CS];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Increased IgG Production [PE];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC]

Labeler Information

Labeler Name: Guna spa
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:5/27/2010

Package Information

No. Package Code Package Description Billing Unit
117089-420-181 BOTTLE, DROPPER in 1 BOX (17089-420-18) / 30 mL in 1 BOTTLE, DROPPER

NDC Record

Field Name Field Value Definition
PRODUCT NDC17089-420The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEMICOXThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEASPERGILLUS NIGER VAR. NIGER - CANDIDA ALBICANS - CENTELLA ASIATICA - MALIC ACID - MERCURIC CHLORIDE - RHIZOPUS STOLONIFER - SODIUM DIETHYL OXALACETATE - SULFUR - TABEBUIA IMPETIGINOSA BARK -The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMESOLUTION/ DROPSThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE5/27/2010This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEGuna spaName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEASPERGILLUS NIGER VAR. NIGER; CANDIDA ALBICANS; CENTELLA ASIATICA; MALIC ACID; MERCURIC CHLORIDE; RHIZOPUS STOLONIFER; SODIUM DIETHYL OXALACETATE; SULFUR; TABEBUIA IMPETIGINOSA BARKAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH30; 30; 6; 12; 6; 30; 12; 6; 4 
ACTIVE INGRED UNIT[hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL; [hp_X]/30mL 
PHARM CLASSESAllergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023